ABCL
AbCellera Biologics Inc.
$4.15
+$0.23(+6.01%)
26
Overall
--
Value
30
Tech
23
Quality
Market Cap
$1.44B
Volume
5.30M
52W Range
$1.89 - $6.52
Target Price
$9.14
EPS Estimates Overview
| Current Quarter | $-0.16 | Next Quarter | $-0.12 |
| Current Year | $-0.61 | Next Year | $-0.49 |
| QoQ Growth | +25.0% | YoY Growth | +19.7% |
| 3Y EPS CAGR | N/A | Target Price | $9.14 |
| Consensus | Buy | Upside | +120.5% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABCL | $4.15 | +6.0% | 5.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get AbCellera Biologics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW